Intramedullary Nails Market, By Product Type (Lower Bone Extremities Product and Upper Bone Extremities Product), By Application (Proximal Bone, Distal Bone, Medical Bone, Lateral Bone, and Others), By Patient Type (Adults and Pediatrics), By End User (Research Institutes and Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)-Trends, Analysis and Forecast Till 20324

Intramedullary Nails Market was valued at US$ 1 Billion in 2024 and is projected to grow at a CAGR of 4.00%to reach US$ 1.5Billion by 2034.

[PDF] Intramedullary nails are utilized in the medullary cavity of the bone when operating on the tibia, radius, and ulna bones. Orthopedic procedures utilize intramedullary nails, also known as intramedullary rods or inter-locking nails, which are typically triangular, come in V-shapes, and are later converted into a rotationally stable clover-leaf shape.

The rise in the prevalence of accidents leading to fractures and orthopedic surgeries is the key factor leading to the growth of the target market. The increase in the cases of bone fractures and other bone related issues especially in the aging population has been leading to a rising demand for intramedullary nails, eventually leading to the growth of the Intramedullary Nails Market.

                 For More Report Details, Download Free Sample PDF

The number of operations conducted to heal fractured bones and other bone related surgeries is anticipated to have a significant impact on the growth of the worldwide intramedullary nail market. In addition, there has been an increased usage of intramedullary nails to treat proximal humerus two-part fractures in numerous clinical bodies. The "gold standard" therapy for femoral shaft fractures has also been identified as intramedullary nail fixation; this development is predicted to fuel the growth of the Intramedullary Nails Market over the forecast period.

For instance, in October 2022, according to The Times of India, it was reported that after the Covid19 pandemic, there has been a significant increase in the number of patients suffering from osteoporosis. Furthermore, it was concluded that in the past two years, more than a hundred patients had been treated for osteoporosis, out of which majority were women aged between 55 to 75 years of age.   

Various advantages offered by intramedullary nails to fuel market growth

The numerous advantages offered by the intramedullary nails is another key factor leading to the growth of the target market. They offer various advantages like minimal soft tissue disruption, low risk of infection and early mobilization. Additionally, nowadays due to the advanced technology; certain biodegradable implants (intramedullary nails) have been made available, which is further boosting the growth of the Intramedullary Nails Market.

For instance, in December 2020, an article published in a journal named – “Journal of Materials Chemistry B” reported a novel device containing biodegradable IN (BIN) which first time made with bioceramics. These BINs consist of high strength and durability and could fix and support tibial fracture model as well as promote osteogenesis.

Restrains:

The major factor restraining the growth of the target market is the risk involved regarding implant failure. Implant failure occurs if the host body starts reacting (immunologically) against the implant after the implantation has been done. This occurs if the implant is not biocompatible with the host body and is defined as intramedullary nail or plate breakage.

For instance, according to PubMed Central, a study including the patients of femoral implant between 2011 and 2019 was carried out, in which it was concluded that total 37 patients with implant failures were found. The mean age at the time of implant failure was found to be 65.5±15.1 years and the gender was equally distributed at 50.0% between males and females.

Intramedullary Nails Market is segmented based on Product Type, Application, Patient Type, End User, and Region.

Product Type Insight

Based on Product Type, Intramedullary Nails Market is segmented into Lower Bone Extremities Product and Upper Bone Extremities Product.

Application Insights

Based on Application, Intramedullary Nails Market is segmented into Proximal Bone, Distal Bone, Medical Bone, Lateral Bone, and Others.

Patient Type Insights

Based on Patient Type, Intramedullary Nails Market is segmented into Adults and Paediatrics.

End-User Insights

Based on End User, Intramedullary Nails Market is segmented into Research Institutes and Hospitals, Ambulatory Surgical Centers, Orthopedic Clinics, and Others. The Research Institutes and Hospitals segment is expected to dominate the growth of the target market, as it has been owing to the increase in prevalence or burden of fracture operations and other bone related surgeries as well as due to increasing number of patient admissions.

Regional Insights:

On the basis of Region, the Intramedullary Nails Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific market is expected tom dominate the growth of the target market, owing to the increasing prevalence of bone structures, their aging population, improved healthcare facilities with skilled medical staff and improved R&D (research and development) activities is anticipated to increase the demand for Intramedullary Nails Market in the Asia Pacific region.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Intramedullary Nails Market report based on Product Type, Application, Patient Type, End-User and Region:

Intramedullary Nails Market, By Product Type:

• Lower Bone Extremities Product
• Upper Bone Extremities Product

Intramedullary Nails Market, By Application:

• Proximal Bone
• Distal Bone
• Medical Bone
• Lateral Bone
• Others

Intramedullary Nails Market, By Patient Type:

• Adults
• Pediatrics

Intramedullary Nails Market, By End-User:

• Research Institutes and Hospitals
• Ambulatory Surgical Centers
• Orthopedic Clinics
• Others

Intramedullary Nails Market, By Region:

• • • North America
      • • U.S.
        • Canada
    • Europe
      • • Germany
        • UK
        • France
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • • China
        • India
        • Japan
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • • GCC
        • Israel
        • South Africa
        • Rest of Middle East & Africa

The key players operating the Intramedullary Nails Market includes, SuZhou Xinrong Best Medical Instrument Co., Ltd, Jiangsu Jinlu Group Co., Ltd., Orthofix Inc, AAP Implantate AG, CarboFix Orthopedics Ltd, Mizuho OSI, Inc, Wuhan Dragonbio Surgical Implant Co., Ltd, PW Medtech Group Limited, Naton Medical Finland Oy, and Shandong Weigao Group Medical Polymer Company Limited.

Recent Development:

• In September 2022, Strykers introduced their new “Gamma4 (Hip Fracture Nailing System)” adding on to the product's 30-year history of consistent innovation and clinical success. With this system, surgeons have access to the most recent Stryker intramedullary nailing technologies. The Gamma 4 method is used to treat femur bone abnormalities, stabilize bones, as well as to support intertrochanteric fractures.
• In July 2022, Orthofix Medical Inc. and Lima Corporate S.p.A. established a licencing collaboration for the U.S. market to offer cutting-edge treatments for patients who struggle with high chronic hip dislocation rates. Orthofix’s specialized limb-lengthening technology patented the Fitbone intramedullary nail system with LimaCorporates proprietary - 3D-printed pelvic fixation device. The gadget corrects leg-length disparity, eases spinal strain, and enables complete hip replacement, all of which help surgeons to divert the femur to the anatomically correct position.
• In January 2018, the FDA (Food and Drug Administration) approved a system named “Apex Tibial Nailing System” by OrthoXel DAC . This system allows secondary bone healing along with a controlled axial micromotion with exceptional torsional stability.

• SuZhou Xinrong Best Medical Instrument Co., Ltd
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Jiangsu Jinlu Group Co., Ltd.
• Orthofix Inc
• AAP Implantate AG
• CarboFix Orthopedics Ltd.
• Mizuho OSI, Inc.
• Wuhan Dragonbio Surgical Implant Co., Ltd.
• PW Medtech Group Limited
• Naton Medical Finland Oy
• Shandong Weigao Group Medical Polymer Company Limited.

“*” marked represents similar segmentation in other categories in the respective section.